These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32558301)

  • 1. Controlling PROTACs with Light.
    Verma S; Manna D
    ChemMedChem; 2020 Jul; 15(14):1258-1261. PubMed ID: 32558301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light-Induced Protein Degradation with Photocaged PROTACs.
    Xue G; Wang K; Zhou D; Zhong H; Pan Z
    J Am Chem Soc; 2019 Nov; 141(46):18370-18374. PubMed ID: 31566962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule PROTACs: novel agents for cancer therapy.
    Wan Y; Yan C; Gao H; Liu T
    Future Med Chem; 2020 May; 12(10):915-938. PubMed ID: 32270707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROTAC-DB: an online database of PROTACs.
    Weng G; Shen C; Cao D; Gao J; Dong X; He Q; Yang B; Li D; Wu J; Hou T
    Nucleic Acids Res; 2021 Jan; 49(D1):D1381-D1387. PubMed ID: 33010159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs.
    An S; Fu L
    EBioMedicine; 2018 Oct; 36():553-562. PubMed ID: 30224312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROTACs: A novel strategy for cancer therapy.
    Liu J; Ma J; Liu Y; Xia J; Li Y; Wang ZP; Wei W
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):171-179. PubMed ID: 32058059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation.
    Xu H; Ohoka N; Inoue T; Yokoo H; Demizu Y
    Bioorg Med Chem Lett; 2024 Jul; 107():129778. PubMed ID: 38702019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROTACs: New method to degrade transcription regulating proteins.
    Hu B; Zhou Y; Sun D; Yang Y; Liu Y; Li X; Li H; Chen L
    Eur J Med Chem; 2020 Dec; 207():112698. PubMed ID: 32858471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
    Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM
    Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives.
    Wang C; Zhang Y; Wang J; Xing D
    Eur J Med Chem; 2022 Jan; 227():113906. PubMed ID: 34656901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROTACs to address the challenges facing small molecule inhibitors.
    Martín-Acosta P; Xiao X
    Eur J Med Chem; 2021 Jan; 210():112993. PubMed ID: 33189436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optochemical Control of Protein Degradation.
    Wu P; Manna D
    Chembiochem; 2020 Aug; 21(16):2250-2252. PubMed ID: 32227452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications.
    Goracci L; Desantis J; Valeri A; Castellani B; Eleuteri M; Cruciani G
    J Med Chem; 2020 Oct; 63(20):11615-11638. PubMed ID: 33026811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs.
    Gong L; Cui D; Xiong X; Zhao Y
    Adv Exp Med Biol; 2020; 1217():317-347. PubMed ID: 31898236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modular PROTAC design for target destruction using a degradation signal based on a single amino acid.
    Shanmugasundaram K; Shao P; Chen H; Campos B; McHardy SF; Luo T; Rao H
    J Biol Chem; 2019 Oct; 294(41):15172-15175. PubMed ID: 31511327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
    Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
    Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted protein degradation: A promise for undruggable proteins.
    Samarasinghe KTG; Crews CM
    Cell Chem Biol; 2021 Jul; 28(7):934-951. PubMed ID: 34004187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs).
    Tomaselli D; Mautone N; Mai A; Rotili D
    Eur J Med Chem; 2020 Dec; 207():112750. PubMed ID: 32871345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of reversible and irreversible covalent chemistry in targeted protein degradation.
    Kiely-Collins H; Winter GE; Bernardes GJL
    Cell Chem Biol; 2021 Jul; 28(7):952-968. PubMed ID: 33789091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PhotoPROTACs: A Novel Biotechnology for Cancer Treatment.
    Wang ZW; Liu Y; Zhu X
    Trends Cell Biol; 2020 Oct; 30(10):749-751. PubMed ID: 32855019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.